DiamiR Biosciences and Aptorum Group (APM) announced that DiamiR received a Clinical Laboratory Evaluation Program, CLEP, Test Approval for its APOE Genotyping test from the New York State Department of Health, NYSDOH. This milestone allows DiamiR to offer its validated APOE Genotyping molecular testing in a variety of biological samples, such as blood, buccal swab, saliva, and tissue, through its Clinical Laboratory Improvement Amendments certified, College of American Pathologists accredited clinical laboratory by licensed healthcare providers in New York State and nationwide.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APM: